MeSH Browser

MeSH Heading: Sertraline
Tree Number(s): D02.092.705.800; D02.455.426.559.847.638.845.800; D04.615.638.845.800
Unique ID: D020280
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D020280
Scope Note: A selective serotonin uptake inhibitor that is used in the treatment of depression.
Entry Term(s): Altruline; Apo-Sertraline; Aremis; Besitran; Gen-Sertraline; Gladem; Lustral; Novo-Sertraline; Rhoxal-sertraline; Sealdin; Sertraline Hydrochloride; Sertraline Hydrochloride (1S-cis)-Isomer; Zoloft; ratio-Sertraline
Pharm Action: Antidepressive Agents
Selective Serotonin Reuptake Inhibitors
Registry Numbers: QUC7NX6WMB; 0; UTI8907Y6X
Related Numbers: 79559-97-0; 79617-96-2; UTI8907Y6X
CAS Type 1 Name: 1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-
Previous Indexing: 1-Naphthylamine/analogs & derivatives (1983-1998)
Public MeSH Note: 99; SERTRALINE was indexed under 1-NAPHTHYLAMINE/analogs & derivatives 1983-98
History Note: 99; use SERTRALINE (NM) 1983-98
Date Established: 1999/01/01
Date of Entry: 1998/06/11
Revision Date: 2022/07/18

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Sertraline MeSH Descriptor Data 2025